Literature DB >> 19335945

Lessons from tuberculosis control for public health.

T R Frieden1.   

Abstract

Tuberculosis (TB) control in many ways exemplifies evidence-based public health practice, rigorously implemented, with appropriate emphasis on the central importance of political support for success. With more than 30 million patients treated in the past decade, TB control has important implications for managing both communicable and non-communicable diseases. Simple diagnostic tests, meticulously proven standardized treatment regimens with assured drug supply, supportive case management and a superb information system that tracks the progress of every patient, all facilitate effective program implementation. TB control shows that public health programs, including those that require long-term treatment in the primary care system, can be effective in poor countries; however, TB rates are heavily influenced by the social, environmental and epidemiologic context, emphasizing that treatment is not enough and that socio-economic factors may be more important determinants of epidemiologic trends than treatment programs. TB control is effective when it combines two essential components: a practical, implementable, proven technical package, and political commitment. Political commitment is also essential to implement other interventions that can improve health, including healthier air, water and food, as well as programs to prevent or reduce tobacco smoking, cardiovascular disease, cancer, obesity and other growing public health problems. By implementing evidence-based practices, ensuring operational excellence, using information systems that facilitate accountability and evaluation, and obtaining and maintaining political support, we can address the public health challenges of the twenty-first century.

Entities:  

Mesh:

Year:  2009        PMID: 19335945

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB.

Authors:  Victoria M Beltran; Kathleen McDavid Harrison; H Irene Hall; Hazel D Dean
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

Review 2.  Epidemiology and challenges to the elimination of global tuberculosis.

Authors:  Mandeep S Jassal; William R Bishai
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  Is there an association between PEPFAR funding and improvement in national health indicators in Africa? A retrospective study.

Authors:  Herbert C Duber; Thomas J Coates; Greg Szekeras; Amy H Kaji; Roger J Lewis
Journal:  J Int AIDS Soc       Date:  2010-06-12       Impact factor: 5.396

4.  Program sustainability post PEPFAR direct service support in the Western Cape, South Africa.

Authors:  Jessica Chiliza; Richard Laing; Frank Goodrich Feeley; Christina P C Borba
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

5.  Tuberculosis in native Israeli Arabs and Jews: trends and treatment outcomes, 1999-2011.

Authors:  H Bishara; D Goldblatt; E Rorman; Z Mor
Journal:  Epidemiol Infect       Date:  2015-04-17       Impact factor: 4.434

6.  Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis.

Authors:  David W Dowdy; Adithya Cattamanchi; Karen R Steingart; Madhukar Pai
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

7.  Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes.

Authors:  Graham H Bothamley; Michelle E Kruijshaar; Heinke Kunst; Gerrit Woltmann; Mark Cotton; Dinesh Saralaya; Mark A Woodhead; John P Watson; Ann L N Chapman
Journal:  BMC Public Health       Date:  2011-11-28       Impact factor: 3.295

8.  India's contribution to global TB control: innovative & integrated implementation research.

Authors:  Peter M Small; V M Katoch
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.